Glucometer last clinical trial – November 3, 2010
The trial has been approved and will be supervised by Prof. Eli Zuckerman, Head of the Liver Unit at the Carmel Medical Center, Haifa, Israel.
Participating in the trail will be a range of individuals with different levels of Diabetes. The trial will be conducted by the diabetics themselves in their homes by using personal calibration mechanism whereas the goal of the trail is compared the invasive and non-invasive readings in a non-clinical environment and performed completely by the participant.
There was a great response from the participants when recruitment started. Because of this, the participants were carefully selected.
Q1 is our target date for the launch of the Glucometer-Combo (as previously announced).